3Amoah A G, Owusu S K, Schuster D P, et al. Pathogenic mechanism of type 2 diabetes in Chanaians-the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. Afr Med 2002 92(5) : 377 - 384.
5Zavaronl I,Bonini I.Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus: the Barilla factory revisited.Metabolism,1999,48 (8) :984-994.
6Pimenta W,Korytkowski M.Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM:ebidence from studies in normal glucose-tolerant individuals with first-degree NIDDM relatives.JAMA,1995,273(23):1855-1861.
7Tripathy D,Carisson M.Insulin secretion and insulin sensitivity in relation to glucose tolerance.Boinia study.Diabetes,2000,49 (6 ): 975-980.
8Kim DJ,Lee MS.Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus.Metabolism ,2001,50(5) :590-593.
9Duman BS,Turkoglu C.The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.Diabetes Nutr Metab,2003,16 (4) :243-250.
10Shin CS,Lee HK.Risk factors for the development of NIDDM in Younchon county,Korea.Diabetes Care,1997,20 (12): 1842-1846.
7Li YB, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function [J]. Diabetes Care,20(M,27(11):2597-2602.
8Wainsteiu J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients [J]. Diabet Meal,2005, 22(8): 1037-1046.
9Weng JP, Cheng H, Li YB, et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trial [J]. Lancet, 2008,371 (9626): 1753-1760.
10Klonott DC. Continuous glucose monitoring, roadmap for 21st certain diabetes therapy [ J ]. Diabetes Care, 2005,28 ( 5 ) : 1231.
